NCT01587781View on ClinicalTrials.gov

Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Obesity
Trial Locations (1)

20010

Children's National Medical Center, Washington D.C.

All Listed Sponsors
lead

Janelle Vaughns

OTHER

NCT01587781 - Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery | Biotech Hunter | Biotech Hunter